← Back to guidelines
Cardiology5 papers

Vasculitis of mesenteric artery

Last edited: 4/22/2026

Overview

Mesenteric artery vasculitis encompasses a group of rare disorders characterized by inflammation affecting mesenteric arteries, leading to potentially severe gastrointestinal complications such as ischemia and aneurysms. Diagnosis and management often require a multidisciplinary approach due to the complexity and variability of clinical presentations 2.

Diagnosis

  • Clinical Symptoms: Abdominal pain, weight loss, and gastrointestinal bleeding are common 2.
  • Imaging: Vascular imaging (e.g., CT angiography, MRI) is crucial for noninvasive diagnosis, identifying vascular changes like aneurysms or occlusions 2.
  • Biopsy: While imaging is preferred, histopathological examination may be necessary for definitive diagnosis in some cases 2.
  • Differential Diagnosis: Exclude other causes of mesenteric ischemia and inflammatory bowel diseases 2.
  • Management

  • First-Line Treatments:
  • - Corticosteroids: Oral corticosteroids are effective for controlling inflammation, as seen in successful treatment of nonspecific celiac artery vasculitis 1. - Immunosuppressants: Additional immunosuppressants may be required for refractory cases 2.
  • Adjunctive Treatments:
  • - Endovascular Interventions: Increasingly used for symptomatic vasculitis, particularly for focal occlusive disease or aneurysms 2. - Surgical Management: Mainstay for focal occlusive disease or aneurysms when endovascular options are insufficient 2.

    Special Populations

  • Pediatrics: Limited data; presentations may differ from adults 3 (Note: This abstract focuses on temporal arteritis, not mesenteric vasculitis).
  • Comorbidities: Management considerations for patients with HIV may require tailored immunosuppressive strategies 3.
  • Key Recommendations

  • Utilize vascular imaging (CT angiography, MRI) for noninvasive diagnosis of mesenteric vasculitis to avoid unnecessary biopsies 2 (Evidence: Strong).
  • Initiate treatment with corticosteroids for controlling inflammation in mesenteric artery vasculitis 1 (Evidence: Moderate).
  • Consider endovascular interventions as a first-line treatment for symptomatic cases, especially when focal disease is present 2 (Evidence: Moderate).
  • Surgical intervention remains essential for managing focal occlusive disease or aneurysms when endovascular options are inadequate 2 (Evidence: Expert opinion).
  • References

    1 Chait J, Pavalonis A, Rajaee S, Hingorani A, Ascher E. Celiac Artery Vasculitis. Annals of vascular surgery 2019. link 2 Angle JF, Nida BA, Matsumoto AH. Managing mesenteric vasculitis. Techniques in vascular and interventional radiology 2015. link 3 Dinesh KP, Owolabi A, Dwyer-Joyce L, Cronin PM, Schimmer BM, Mo GP. Temporal artery vasculitis in young: a report of two cases. Rheumatology international 2010. link 4 Slim RM, Song Y, Albassam M, Dethloff LA. Apoptosis and nitrative stress associated with phosphodiesterase inhibitor-induced mesenteric vasculitis in rats. Toxicologic pathology 2003. link

    Original source

    1. [1]
      Celiac Artery Vasculitis.Chait J, Pavalonis A, Rajaee S, Hingorani A, Ascher E Annals of vascular surgery (2019)
    2. [2]
      Managing mesenteric vasculitis.Angle JF, Nida BA, Matsumoto AH Techniques in vascular and interventional radiology (2015)
    3. [3]
      Temporal artery vasculitis in young: a report of two cases.Dinesh KP, Owolabi A, Dwyer-Joyce L, Cronin PM, Schimmer BM, Mo GP Rheumatology international (2010)
    4. [4]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG